Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29286X101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Deep Track Capital, LP
13G/A
Amendment 1
|
0% |
8/14/2026
Event 6/30/2026
|
|
| Deep Track Capital, LP | 0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 0% | ||
| David Kroin | 0% | ||
|
Invus Global Management, LLC
13G/A
Amendment 2
|
9.3% |
8/13/2026
Event 6/30/2026
|
|
| Invus Public Equities, L.P. | 8.2% | ||
| Invus Public Equities Advisors, LLC | 8.2% | ||
| Invus Global Management, LLC | 8.2% | ||
| Siren, L.L.C. | 8.2% | ||
| Avicenna Life Sci Master Fund LP | 1.2% | ||
| Avicenna Life Sci Master GP LLC | 1.2% | ||
| Ulys, L.L.C. | 1.2% | ||
| Raymond Debbane | 9.3% | ||
| Blue Owl Capital Holdings LP 13G/A Amendment 2 | 0.8% |
8/12/2026
Event 6/30/2026
|
|
|
Invus Global Management, LLC
13G/A
Amendment 1
|
7.8% |
5/5/2026
Event 3/31/2026
|
|
| Invus Public Equities, L.P. | 6.7% | ||
| Invus Public Equities Advisors, LLC | 6.7% | ||
| Invus Global Management, LLC | 6.7% | ||
| Siren, L.L.C. | 6.7% | ||
| Avicenna Life Sci Master Fund LP | 1.1% | ||
| Avicenna Life Sci Master GP LLC | 1.1% | ||
| Ulys, L.L.C. | 1.1% | ||
| Raymond Debbane | 7.8% |